z-logo
open-access-imgOpen Access
Pathogen blockade of TAK1 triggers caspase-8–dependent cleavage of gasdermin D and cell death
Author(s) -
Pontus Ørning,
Dan Weng,
Kristian K. Starheim,
Dmitry Ratner,
Zachary Best,
Bettina Lee,
Alexandria Brooks,
Shiyu Xia,
Hao Wu,
Michelle A. Kelliher,
Scott B. Berger,
Peter J. Gough,
John Bertin,
Megan K. Proulx,
Jon D. Goguen,
Nobuhiko Kayagaki,
Katherine A. Fitzgerald,
Egil Lien
Publication year - 2018
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.aau2818
Subject(s) - pyroptosis , inflammasome , caspase 1 , effector , microbiology and biotechnology , programmed cell death , cleavage (geology) , pathogen , caspase , receptor , inflammation , biology , chemistry , apoptosis , immunology , biochemistry , paleontology , fracture (geology)
Limited proteolysis of gasdermin D (GSDMD) generates an N-terminal pore-forming fragment that controls pyroptosis in macrophages. GSDMD is processed via inflammasome-activated caspase-1 or -11. It is currently unknown whether macrophage GSDMD can be processed by other mechanisms. Here, we describe an additional pathway controlling GSDMD processing. The inhibition of TAK1 or IκB kinase (IKK) by the Yersinia effector protein YopJ elicits RIPK1- and caspase-8-dependent cleavage of GSDMD, which subsequently results in cell death. GSDMD processing also contributes to the NLRP3 inflammasome-dependent release of interleukin-1β (IL-1β). Thus, caspase-8 acts as a regulator of GSDMD-driven cell death. Furthermore, this study establishes the importance of TAK1 and IKK activity in the control of GSDMD cleavage and cytotoxicity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom